Table 2.
Summary statistics for baseline and maximal skin blood flow responses across microdialysis treatment groups
Non‐Hispanic Black | Non‐Hispanic White | |||
---|---|---|---|---|
Normotensive (n = 4) |
Prehypertensive (n = 4) |
Normotensive (n = 4) |
Prehypertensive (n = 4) |
|
Baseline (%CVCmax) | ||||
Control | 14 ± 8 | 13 ± 5 | 15 ± 5 | 19 ± 9 |
L‐NAME | 10 ± 2 | 17 ± 11 | 11 ± 4 | 11 ± 4 |
SNP | 28 ± 4* | 13 ± 6 | 19 ± 8 | 35 ± 14 # |
Maximal (CVC) | ||||
Control | 2.82 ± 0.71 | 2.59 ± 0.48 | 3.12 ± 0.65 | 2.96 ± 0.31 |
L‐NAME | 2.48 ± 0.93 | 1.87 ± 0.20 | 2.37 ± 0.25 | 2.27 ± 0.41 |
SNP | 2.88 ± 0.55 | 2.74 ± 0.57 | 2.79 ± 0.44 | 2.60 ± 0.43 |
Abbreviations: CVC, cutaneous vascular conductance; L‐NAME, NG‐nitro‐l‐arginine methyl ester; SNP, sodium nitroprusside.
p < .05 versus control
p < .05 versus L‐NAME.